We also heard from Pharmac. Basically the annual review predated the announcement of the terms of reference for the Pharmac review. But what we did discuss was the work that Pharmac had done in relation to the disruption to global manufacturing and supply chain pharmaceuticals, and the work that they'd been doing there to make sure we had a steady supply of pharmaceuticals.